Cargando…
Optimal time for the resumption of biologics after COVID-19
Autores principales: | Kow, Chia Siang, Hasan, Syed Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513688/ https://www.ncbi.nlm.nih.gov/pubmed/34173559 http://dx.doi.org/10.1016/j.jdin.2020.09.003 |
Ejemplares similares
-
Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020) -
Caution in the time of rashes and COVID-19
por: Vesely, Matthew D., et al.
Publicado: (2020) -
Optimizing education for dermatology residents during the COVID-19 pandemic
por: Patel, Parth, et al.
Publicado: (2020) -
Optimizing care for atopic dermatitis patients during the COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020) -
Optimizing teledermatology visits for dermatology resident education during the COVID-19 pandemic
por: Oldenburg, Reid, et al.
Publicado: (2020)